The prevalence of protein C, protein S, and antithrombin III 111 deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia

Clinical and Applied Thrombosis/Hemostasis

Volumn 9, Issue 2, 2003, Pages 155-162

  Chen, Wei Hsi ^a   Lan, Min Yu ^a   Chang, Yung Yee ^a   Chen, Shun Sheng ^a   Liu, Jia Shou ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antithrombin III; Cerebral ischemia; Chinese; Protein C; Protein S

Indexed keywords

ANTITHROMBIN III; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; FIBRINOGEN; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; THROMBIN; THROMBIN INHIBITOR;

ADULT; AGED; ANTITHROMBIN III DEFICIENCY; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CHINESE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY;

EID: 0038047729     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960300900211     Document Type: Article

References (31)

1. Tatlisumak T, Fisher M. Hematologic disorders associated with ischemic stroke. J Neurol Sci 1996;140:1.
2. Berge E, Friis P, Sandset PM. Hemostatic activation in acute ischemic stroke. Thromb Res 2001;101:13.
3. Hankey GJ, Eikelboom JW, van Bockxmeer FM, et al. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001;32:1793.
4. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999;100:736.
5. De Lucia D, d'Alessio D, Pezzella S, et al. A hypercoagulable state in activated protein C resistant patients with ischemic stroke. Int J Clin Lab Res 1998;28:74.
6. Douay X, Lucas C, Caron C, et al. Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand 1998;98:124.
7. Tosetto A, Ruggeri M, Castaman G, et al. Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study. Blood Coag Fibrinolysis 1997;8:397.
8. Martinez HR, Rangel-Guerra RA, Marfil LJ. Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993;24:19.
9. Barinagarrementeria F, Cantu-Brito C, De La Pena A, et al. Prothrombotic states in young people with idiopathic stroke. A prospective study. Stroke 1994;25:287.
10. Munts AG, van Genderen PJ, Dippel DW, et al. Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol 1998;245:21.
11. Mayer SA, Sacco RL, Hurlet-Jensen A, et al. Free protein S deficiency in acute ischemic stroke. A case-control study. Stroke 1993;24:224.
12. Ernerudh J, Olsson JE, von Schenck H. Antithrombin-III deficiency in ischemic stroke. Stroke 1990;21:967.
13. Camerlingo M, Finazzi G, Casto L, et al. Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults. Neurology 1991;41:1371.
14. Bushnell CD, Goldstein LB. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 2000;31:3067.
15. de Groot PG, Derksen R. The influence of antiphospholipid antibodies on the protein C pathway. In: Hughes Syndrome. Khamashta MA, ed. New York: Springer, 2001:307.
16. Hwang KK, Grossman JM, Visvanathan S, et al. Identification of anti-thrombin antibodies in the antiphospholipid syndrome that interfere with the inactivation of thrombin by antithrombin. J Immunol 2001;167:7192.
17. Chen WH, Kao YF, Lan MY, et al. A pertubation of antithrombin III and protein coupling associates with an increase of anti-beta2 glycoprotein I antibody in non-APS cerebral ischemia. Blood Coag Fibrinolysis 2002;13:703.
18. Chen WH, Chang YY, Chou MS, et al. The lipoprotein profile of young adults with cerebral atherosclerosis. Southeast Asian J Trop Med Publ Health 1996;27:178.
19. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752.
20. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythrematosus. Arthritis Rheum 1982;25:1271.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythrematosus. Arthritis Rheum 1997;40: 1725.
22. Aiach M, Borgel D, Gaussem P, et al. Protein C and protein S deficiencies. Semin Hematol 1997;34:205.
23. Boerger LM, Morris PC, Thurnau GR, et al. Oral contraceptives and gender affect protein S status. Blood 1987;69:692.
24. Van Bovan HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol 1997;34:188.
25. Edelberg JM, Christie PD, Rosenberg RD. Regulation of vascular bed-specific prothrombotic potential. Circ Res 2001;89:117.
26. Aird WC. Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis. Crit Care Med 2001; 29(Suppl):S28.
27. Speiser W, Anders E, Preissner KT, et al. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins. Blood 1987;69:964.
28. Bajaj MS, Kuppuswamy MN, Manepalli AN, et al. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Thromb Haemost 1999;82:1047.
29. Ishii H, Salem HH, Bell CE, et al. Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain. Blood 1986;67:362.
30. Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001;29(Suppl):S48.
31. Smiley ST, Stitt TN, Grusby MJ. Cross-linking of protein S bound to lymphocytes promotes aggregation and inhibits proliferation. Cell Immunol 1997;181:120.